DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Kohne C, de Greve J, Bokemeyer C. et al.
Capecitabine plus irinotecan versus 5-FU/FA/irinotecan ± celecoxib in first line treatment of metastatic colorectal cancer. Safety results of the prospective multicenter EORTC phase III study 40 015.
ASCO 2005; Abstract: 3525-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.